Zobrazeno 1 - 10
of 462
pro vyhledávání: '"Ciammella P"'
Autor:
Alessio Bruni, Vieri Scotti, Maria Alessia Zerella, Federica Bertolini, Jessica Imbrescia, Emanuela Olmetto, Chiara Bennati, Francesco Cuccia, Marianna Miele, Niccolò Giaj-Levra, Marcello Tiseo, Patrizia Ciammella, Stefano Vagge, Marco Galaverni, Antonio Pontoriero, Serena Badellino, Ruggero Spoto, Emanuele Alì, Paolo Borghetti
Publikováno v:
Current Oncology, Vol 31, Iss 11, Pp 6791-6802 (2024)
Background: Extensive-stage small-cell lung cancer (ES-SCLC) treatment has recently been revolutionized by the advent of immune checkpoint inhibitors. This survey was conducted to evaluate the current pattern of care among Italian clinicians, in part
Externí odkaz:
https://doaj.org/article/8c657a1bea55428498d34790187b009a
Autor:
Federico Iori, MD, Valeria Trojani, MSc, Alice Zamagni, PhD, Patrizia Ciammella, MD, Mauro Iori, PhD, Andrea Botti, MSc, Cinzia Iotti, MD
Publikováno v:
Advances in Radiation Oncology, Vol 10, Iss 1, Pp 101665- (2025)
Purpose: Spatially fractionated radiation therapy (SFRT) is an irradiation technique developed to improve large cancer response. Although preliminary studies report highly positive results, data are still limited. The aim of this retrospective monoce
Externí odkaz:
https://doaj.org/article/a3b1196b71eb43848ed20c90e0dee883
Autor:
Patrizia Ciammella, Salvatore Cozzi, Paolo Borghetti, Marco Galaverni, Valerio Nardone, Maria Paola Ruggieri, Matteo Sepulcri, Vieri Scotti, Alessio Bruni, Francesca Zanelli, Roberto Piro, Elena Tagliavini, Andrea Botti, Federico Iori, Emanuele Alì, Chiara Bennati, Marcello Tiseo
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundChemoradiation therapy (CRT) is the treatment of choice for locally advanced non-small cell lung cancer (LA-NSCLC). Several clinical trials that combine programmed cell death 1 (PD1) axis inhibitors with radiotherapy are in development for
Externí odkaz:
https://doaj.org/article/5295884ae5854ba4ba4dd0e47e0a1c72
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fiandra Christian, Filippi Andrea, Catuzzo Paola, Botticella Angela, Ciammella Patrizia, Franco Pierfrancesco, Borca Valeria, Ragona Riccardo, Tofani Santi, Ricardi Umberto
Publikováno v:
Radiation Oncology, Vol 7, Iss 1, p 186 (2012)
Abstract Background Radiotherapy in Hodgkin’s Lymphoma (HL) is currently evolving with new attempts to further reduce radiation volumes to the involved-node concept (Involved Nodes Radiation Therapy, INRT) and with the use of intensity modulated ra
Externí odkaz:
https://doaj.org/article/b90b5f574f8d42a9a75de27f8cb81de9
Publikováno v:
Journal of Medical Case Reports, Vol 6, Iss 1, p 236 (2012)
Abstract Introduction Extraskeletal presentation at diagnosis or during the course of multiple myeloma is a rare event. The prognosis is usually very poor. At the moment there is no agreed gold standard for the treatment of this presentation. Case pr
Externí odkaz:
https://doaj.org/article/45d1a2fffb3c4ce1b9b6547931faa760
Autor:
Filippi Andrea, Giudici Mauro, Clerico Mario, Ciammella Patrizia, Franco Pierfrancesco, Munoz Fernando, Ricardi Umberto
Publikováno v:
Radiation Oncology, Vol 2, Iss 1, p 15 (2007)
Abstract Background Carcinoma of the prostate gland is the most frequent malignant tumour affecting male population. While the large majority of tumours is represented by adenocarcinoma, pure squamous cell carcinoma comprises only 0,5–1% of all pro
Externí odkaz:
https://doaj.org/article/4ff2060f8e104dbcb4b4d6b38d553922
Autor:
Salvatore Cozzi, Lilia Bardoscia, Masoumeh Najafi, Sefik Igdem, Luca Triggiani, Stefano Maria Magrini, Andrea Botti, Ferran Guedea, Laura Melocchi, Patrizia Ciammella, Cinzia Iotti, Cristina Gutierrez
Publikováno v:
Current Urology, Vol 16, Iss 4, Pp 218-226 (2022)
Abstract. Objective. The aim of the study is to evaluate clinical features and outcomes after different therapeutic strategies for ductal prostate adenocarcinoma (DPC), a rare but aggressive subtype of invasive prostate cancer (PCa) accounting for, i
Externí odkaz:
https://doaj.org/article/c15a6f98b3794413a44182164cb0a30d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.